Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Use of Water Jet for Initial Treatment FOR Peri-Implant Disease

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2012 by Rambam Health Care Campus
Information provided by (Responsible Party):
Rambam Health Care Campus Identifier:
First received: January 1, 2012
Last updated: May 6, 2015
Last verified: January 2012
The aim of this study was to evaluate the effect of a dental water jet on initial peri-implant disease resolution.

Condition Intervention Phase
Device: Water jet
Phase 1
Phase 2

Study Type: Interventional
Study Design: Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Single Blind (Investigator)
Primary Purpose: Treatment
Official Title: The Use of Water Jet for Initial Treatment FOR Peri-Implant Disease

Resource links provided by NLM:

Further study details as provided by Rambam Health Care Campus:

Primary Outcome Measures:
  • Probing depth [ Time Frame: one month ] [ Designated as safety issue: No ]
    Probing depth around the implant

Secondary Outcome Measures:
  • Bleeding on probing [ Time Frame: one month ] [ Designated as safety issue: No ]
    Bleeding on probing (BOP) around the implant

Estimated Enrollment: 40
Study Start Date: July 2012
Estimated Study Completion Date: January 2017
Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: water-Jet
use of water jet for 1 month
Device: Water jet
use of water jet for a month
Other Name: silonit water jet

Detailed Description:
Peri-implant disease is becoming more frequent during the last decade. Till today, there is no effective evidence-based treatment. The use of water-jet might improve those situations and reduce morbidity and implant loss.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Signed and dated Informed Consent Form.
  • Patient suffer from peri- implant disease
  • Age Eligible for study: 18 year old and older
  • Genders Eligible for study: Both

Exclusion Criteria:

  • Patient substantially fails to comply with the study schedule, or treatment program as described in this Protocol.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01509898

Contact: Dr. liran Levin, DMD +972502062820

Rambam Hospital Recruiting
Haifa, Israel
Contact: Dr. Liran levin, DMD    972   
Sponsors and Collaborators
Rambam Health Care Campus
Study Director: Dr. Liran Levin, DMD Department of periodontology
  More Information

Responsible Party: Rambam Health Care Campus Identifier: NCT01509898     History of Changes
Other Study ID Numbers: 0374-11-RMB 
Study First Received: January 1, 2012
Last Updated: May 6, 2015
Health Authority: Israel: Ethics Commission

Additional relevant MeSH terms:
Periodontal Diseases
Mouth Diseases
Stomatognathic Diseases processed this record on December 07, 2016